Sotagliflozin vs Dapagliflozin: A Systematic Review Comparing Cardiovascular Mortality

After the debut of the results of the effect of Sotagliflozin on Cardiovascular Events in Patients with Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF) and Sotagliflozin in Patients With Chronic Kidney Disease and Type 2 Diabetes (SCORED) trials at the American Heart Association’s 2020 Sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Iyer, Nandhini, Hussein, Sally, Singareddy, Sanjana, SN, Vijay Prabhu, Jaramillo, Arturo P, Yasir, Mohamed, Nath, Tuheen Sankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585602/
https://www.ncbi.nlm.nih.gov/pubmed/37868384
http://dx.doi.org/10.7759/cureus.45525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585602/
https://www.ncbi.nlm.nih.gov/pubmed/37868384
http://dx.doi.org/10.7759/cureus.45525

Ejemplares similares